Vanda Pharmaceuticals (VNDA)

Trade VNDA now with
1/14/2022 8:38:37 AM Vanda Pharma Settles HETLIOZ Patent Litigation With MSN
8/3/2021 7:21:22 AM Vanda Closes Enrollment In ODYSSEY Study Comparing Tradipitant And Placebo In Hospitalized COVID-19 Pneumonia Patients
8/18/2020 7:14:09 AM Vanda Pharma: Interim Analysis Of ODYSSEY Study Shows Tradipitant May Accelerate Clinical Improvement
8/3/2020 7:15:24 AM Vanda Says FDA Accepted For Priority Review Applications For Smith-Magenis Syndrome
7/13/2020 4:36:18 PM FDA Grants Authorization For Individual Patient Expanded Access Protocol For The Use Of Tradipitant For Gastroparesis
5/20/2020 10:47:12 AM Vanda Pharma CEO's Proposal On Clinical Trial Data Sharing, COVID-19 And Remdesivir
5/13/2020 7:07:12 AM Vanda Pharma Agrees With FDA On Resubmission Of Application For HETLIOZ For Smith-Magenis Syndrome
2/19/2020 7:03:45 AM Vanda Pharmaceuticals Appoints Stephen Ray Mitchell To Its Board
4/6/2018 8:53:19 AM Jefferies Is Cutting VANDA PHARMACEUTICALS (VNDA) 2020 Estimate To 0.61 From 0.67
4/6/2018 8:53:03 AM Jefferies Is Lowering VANDA PHARMACEUTICALS (VNDA) 2019 Estimate To 0.83 From 0.92